Patent assignee · US · COMPANY

ELUCID BIOIMAGING INC.

40Patents
39Active
40Granted
72Portfolio score

Filing activity: Jan 2, 2013 → Jan 17, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US10176408B2 Systems and methods for analyzing pathologies utilizing quantitative imaging Human Necessities 82 Active
US9235887B2 Classification of biological tissue by multi-mode data registration, segmentation and characterization Physics 70 Active
US11087460B2 Methods and systems for training and validating quantitative imaging biomarkers Physics 64 Active
US11120312B2 Quantitative imaging for cancer subtype Human Necessities 63 Active
US11087459B2 Quantitative imaging for fractional flow reserve (FFR) Physics 61 Active
US11113812B2 Quantitative imaging for detecting vulnerable plaque Physics 61 Active
US11094058B2 Systems and method for computer-aided phenotyping (CAP) using radiologic images Physics 61 Active
US11257584B2 Quantitative medical imaging reporting Physics 50 Active
US10755810B2 Methods and systems for representing, storing, and accessing computable medical imaging-derived quantities Physics 37 Active
US11508063B2 Non-invasive measurement of fibrous cap thickness Physics 37 Active
US10740880B2 Systems and methods for analyzing pathologies utilizing quantitative imaging Physics 35 Active
US11676359B2 Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology Physics 22 Active
US11696735B2 Quantitative imaging for instantaneous wave-free ratio Physics 15 Active
US11887701B2 Non-invasive determination of likely response to anti-inflammatory therapies for cardiovascular disease Physics 14 Active
US11607179B2 Non-invasive risk stratification for atherosclerosis Physics 14 Active
US11657486B2 Systems and methods for improving soft tissue contrast, multiscale modeling and spectral CT Physics 14 Active
US11593926B2 Systems and methods for improving soft tissue contrast, multiscale modeling and spectral CT Physics 14 Active
US11869186B2 Non-invasive determination of likely response to combination therapies for cardiovascular disease Physics 13 Active
US11887713B2 Non-invasive determination of likely response to anti-diabetic therapies for cardiovascular disease Physics 13 Active
US11887734B2 Systems and methods for clinical decision support for lipid-lowering therapies for cardiovascular disease Emerging Cross-Sectional Technologies 13 Active
US12045983B2 Functional measures of stenosis significance Physics 12 Active
US12039765B2 Systems and methods for optimizing analysis of CT angiography Physics 12 Active
US11715187B2 Extended tissue types for increased granularity in cardiovascular disease phenotyping Physics 12 Active
US12026868B2 Quantitative imaging for detecting histopathologically defined plaque erosion non-invasively Physics 12 Active
US12008751B2 Quantitative imaging for detecting histopathologically defined plaque fissure non-invasively Physics 9 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.